SPIR vs SRPT · rev $110.5M vs rev $1.90B
Spire Global Inc (SPIR) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Spire Global Inc (SPIR) is a specialty business services company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported SPIR revenue for 2024-12-31 was $110.5M. Net income was -$102.8M. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. SPIR currently screens at market cap $351.2M.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
SPIR currently screens at market cap $351.2M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the SPIR and SRPT stock pages for the full models.
Not investment advice.